The company, called Abisati, will focus solely on 710GO, an oral MC4R agonist that is effective in nonhuman primates and rats. Northbrook, Ill., Nov. 1, 2024 /PRNewswire/ — Endevica Bio, a privately held company developing first-in-class peptide drug candidates, today announced the…